臨床試験を検索:XBI-302 プラセボ
合計58207件
-
Shenzhen Xbiome Biotech Co., Ltd.Beijing Improve-Quality Tech.Co., Ltd.募集
-
Northwestern UniversityBrain & Behavior Research Foundation; Neurocentria, Inc.完了
-
Jubilant Therapeutics Inc.募集
-
Swiss Tropical & Public Health InstitutePevion Biotech Ltd; Mymetics Corporation完了
-
GE HealthcareQuintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion International Corporation終了しました
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)完了
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)まだ募集していません
-
FSD Pharma, Inc.Lucid Psycheceuticals Inc. (sub of FSD Pharma, Inc.)完了
-
The University of Texas at San AntonioNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Maryland と他の協力者完了
-
Threshold Pharmaceuticals完了急性リンパ芽球性白血病 | 慢性リンパ性白血病 | 急性骨髄性白血病 | 慢性骨髄性白血病 | ハイリスク骨髄異形成症候群 | 進行性骨髄線維症アメリカ
-
Memorial Sloan Kettering Cancer CenterBMS Foundation募集
-
Qualigen Theraputics, Inc.Translational Drug Development募集
-
Sarcoma Alliance for Research through CollaborationThreshold Pharmaceuticals利用できない
-
National Institute of Diabetes and Digestive and...まだ募集していません
-
LaNova Australia Pty Limited終了しました
-
Selecta Biosciences, Inc.National Human Genome Research Institute (NHGRI)一時停止
-
Herbert Hurwitz, MDGlaxoSmithKline; National Comprehensive Cancer Network; Threshold Pharmaceuticals完了
-
Seoul National University HospitalThreshold Pharmaceuticals完了
-
Tianjin Medical University Second Hospitalまだ募集していません肺新生物 | オリゴ転移
-
Aevi Genomic Medicine, LLC, a Cerecor company完了
-
Palacky University完了
-
Global Alliance for TB Drug Development完了
-
Guangdong Hengrui Pharmaceutical Co., Ltd募集